6 months ago
2
SeQuent Scientific Limited which is into Animal Health industry, and Viyash Lifesciences Private Limitd an integrated pharmaceutical company, announced that the National Company Law Tribunal (NCLT) has approved the strategy of merger betwixt SeQuent and the Viyash radical of companies.
“The NCLT support marks the opening of a caller section for the combined entity and represents a cardinal translation to leapfrog into the adjacent orbit of the planetary carnal wellness market,” SeQuent said successful a statement.
NCLT acceptable speech insolvency plea against ZTE filed by TVS Supply Chain
“This merger not lone delivers the indispensable standard and capabilities for accelerating integrated maturation successful the Animal Health market, but besides provides fiscal resilience, stability, and absorption bandwidth to rejuvenate SeQuent’s inorganic maturation engine,” it added.
Dr. Haribabu Bodepudi, Founder and CEO, Viyash, said, “This merger creates the level to present world-class solutions for our customers. With our strengths successful R&D, customized improvement capabilities, manufacturing capacities, and a streamlined proviso chain, we would look arsenic an innovative and reliable spouse for our customers crossed the world.”
“Over the past fewer months, we person developed a broad program for integration which leverages synergies for maturation and capability. The momentum reflected successful our caller results is lone the beginning,” helium said.
Rajaram Narayanan, Managing Director and CEO, SeQuent, said, “There are important opportunities to supply relevant, differentiated and prime attraction for animals.”
“With this merger, the institution volition beryllium uniquely positioned to physique a world-class concern and present connected the requirements of favored owners, farmers and carnal wellness professionals. Together, we are gathering a institution that volition acceptable caller benchmarks successful quality, innovation, and lawsuit trust,” helium added.
